HomeENVB • NASDAQ
add
Enveric Biosciences Inc
Previous close
$5.92
Day range
$8.60 - $13.25
Year range
$4.88 - $96.30
Market cap
6.17M USD
Avg Volume
196.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.87M | -10.04% |
Net income | -1.87M | 10.09% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.83M | 8.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.76M | 20.76% |
Total assets | 4.36M | -8.94% |
Total liabilities | 905.88K | 7.95% |
Total equity | 3.46M | — |
Shares outstanding | 596.98K | — |
Price to book | 0.89 | — |
Return on assets | -118.45% | — |
Return on capital | -166.10% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.87M | 10.09% |
Cash from operations | -2.07M | -123.82% |
Cash from investing | — | — |
Cash from financing | 2.99M | 478.02% |
Net change in cash | 907.78K | 332.25% |
Free cash flow | -1.35M | -1,087.41% |
About
Founded
1994
Website
Employees
6
